Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression

As a hallmark of metabolic reprogramming, aerobic glycolysis contributes to tumorigenesis and aggressiveness. However, the mechanisms and therapeutic strategies regulating aerobic glycolysis in neuroblastoma (NB), one of leading causes of cancer-related death in childhood, still remain elusive. Meth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Autores principales: Fang, Erhu, Wang, Xiaojing, Wang, Jianqun, Hu, Anpei, Song, Huajie, Yang, Feng, Li, Dan, Xiao, Wenjing, Chen, Yajun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993229/
https://ncbi.nlm.nih.gov/pubmed/32042322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.37383
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares